Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8+ T cells

2020 ◽  
Vol 5 (51) ◽  
pp. eabb7066 ◽  
Author(s):  
Christian Perez-Shibayama ◽  
Ulrika Islander ◽  
Mechthild Lütge ◽  
Hung-Wei Cheng ◽  
Lucas Onder ◽  
...  

Fibroblastic reticular cells (FRCs) are stromal cells that actively promote the induction of immune responses by coordinating the interaction of innate and adaptive immune cells. However, whether and to which extent immune cell activation is determined by lymph node FRC reprogramming during acute viral infection has remained unexplored. Here, we genetically ablated expression of the type I interferon-α receptor (Ifnar) in Ccl19-Cre+ cells and found that sensing of type I interferon imprints an antiviral state in FRCs and thereby preserves myeloid cell composition in lymph nodes of naive mice. During localized lymphocytic choriomeningitis virus infection, IFNAR signaling precipitated profound phenotypic adaptation of all FRC subsets enhancing antigen presentation, chemokine-driven immune cell recruitment, and immune regulation. The IFNAR-dependent shift of all FRC subsets toward an immunostimulatory state reduced exhaustive CD8+ T cell activation. In sum, these results unveil intricate circuits underlying type I IFN sensing in lymph node FRCs that enable protective antiviral immunity.

2020 ◽  
Vol 13 (5) ◽  
pp. 419-434
Author(s):  
Freddy Gonzalez Badillo ◽  
Flavia Zisi Tegou ◽  
Riccardo Masina ◽  
Shane Wright ◽  
Mackenzie Scully ◽  
...  

2021 ◽  
Author(s):  
Yuhao Shi ◽  
Melissa Dolan ◽  
Michalis Mastri ◽  
James W. Hill ◽  
Adam Dommer ◽  
...  

Therapeutic inhibition of programmed cell death ligand (PD-L1) can reverse PD-1-mediated suppression of tumor-killing T-cells; however, many patients develop resistance. Acquired resistance may be derived from intracellular PD-L1 and interferon (IFN) signaling programs in the tumor that can have dual, sometimes opposing, influences on tumor immune responses. Here we show that PD-L1 inhibition induces a novel secretory program tightly controlled by IFN-signaling and specific to acquired, but not innate, resistance in tumors. A PD-L1 treatment-induced secretome (PTIS) was found to be enriched for several IFN-stimulated genes (ISGs) and then further enhanced by type I IFN stimulation (IFNα or IFNβ) in multiple mouse tumor models. Chronic inhibition or gene knockout of tumor PD-L1 in vitro could elicit similar type I IFN-enhanced secretory stimulation while resistant cells were able to suppress T cell activation and killing ex vivo. When reimplanted into mice, resistant tumors were more sensitive to IL-6 inhibition (a key PTIS component) and growth significantly reduced when type I IFN signaling was blocked. Together, these results show that prolonged PD-L1 inhibition can 'rewire' existing intracellular IFN:PD-L1 signaling crosstalk to drive secretory programs that help protect tumors from immune cell attack and represent a targetable vulnerability to overcome acquired resistance in patients.


1995 ◽  
Vol 8 (3) ◽  
pp. 151-159
Author(s):  
S. Yoshino

We investigated the effect of oral administration of type I interferon (IFN) on antigen-induced arthritis (AIA) in rats that was induced by immunization with methylated bovine serum albumin (mBSA) followed by intraarticular injection of the antigen. When IFN was orally given before immunization, the severity of AIA was significantly suppressed. Oral IFN also downregulated both delayed type hypersensitivity and in vitro proliferative responses to mBSA. The serum from IFN-fed rats decreased joint inflammation as well as proliferation to mBSA. In contrast, in rats fed IFN after the onset of AIA, neither joint swelling nor the proliferation of T cells to mBSA was affected. Feeding IFN before, but not after immunization with mBSA was effective in suppressing the production of IL-2 by lymph node cells. These data suggest that IFN may be active by the oral route and have a preventive effect on antigen-driven inflammatory diseases that appears to be due the suppression of IL-2 production resulting in the downregulatin of the T cell activation.


2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Antonios Psarras ◽  
Adewonuola Alase ◽  
Agne Antanaviciute ◽  
Ian M. Carr ◽  
Md Yuzaiful Md Yusof ◽  
...  

AbstractAutoimmune connective tissue diseases arise in a stepwise fashion from asymptomatic preclinical autoimmunity. Type I interferons have a crucial role in the progression to established autoimmune diseases. The cellular source and regulation in disease initiation of these cytokines is not clear, but plasmacytoid dendritic cells have been thought to contribute to excessive type I interferon production. Here, we show that in preclinical autoimmunity and established systemic lupus erythematosus, plasmacytoid dendritic cells are not effector cells, have lost capacity for Toll-like-receptor-mediated cytokine production and do not induce T cell activation, independent of disease activity and the blood interferon signature. In addition, plasmacytoid dendritic cells have a transcriptional signature indicative of cellular stress and senescence accompanied by increased telomere erosion. In preclinical autoimmunity, we show a marked enrichment of an interferon signature in the skin without infiltrating immune cells, but with interferon-κ production by keratinocytes. In conclusion, non-hematopoietic cellular sources, rather than plasmacytoid dendritic cells, are responsible for interferon production prior to clinical autoimmunity.


2007 ◽  
Vol 82 (4) ◽  
pp. 1870-1883 ◽  
Author(s):  
Ahmad R. Sedaghat ◽  
Jennifer German ◽  
Tanya M. Teslovich ◽  
Joseph Cofrancesco ◽  
Chunfa C. Jie ◽  
...  

ABSTRACT The mechanism of CD4+ T-cell depletion during chronic human immunodeficiency virus type 1 (HIV-1) infection remains unknown. Many studies suggest a significant role for chronic CD4+ T-cell activation. We assumed that the pathogenic process of excessive CD4+ T-cell activation would be reflected in the transcriptional profiles of activated CD4+ T cells. Here we demonstrate that the transcriptional programs of in vivo-activated CD4+ T cells from untreated HIV-positive (HIV+) individuals are clearly different from those of activated CD4+ T cells from HIV-negative (HIV−) individuals. We observed a dramatic up-regulation of cell cycle-associated and interferon-stimulated transcripts in activated CD4+ T cells of untreated HIV+ individuals. Furthermore, we find an enrichment of proliferative and type I interferon-responsive transcription factor binding sites in the promoters of genes that are differentially expressed in activated CD4+ T cells of untreated HIV+ individuals compared to those of HIV− individuals. We confirm these findings by examination of in vivo-activated CD4+ T cells. Taken together, these results suggest that activated CD4+ T cells from untreated HIV+ individuals are in a hyperproliferative state that is modulated by type I interferons. From these results, we propose a new model for CD4+ T-cell depletion during chronic HIV-1 infection.


2018 ◽  
Vol 9 ◽  
Author(s):  
Yohei Takeda ◽  
Masahiro Azuma ◽  
Kenji Funami ◽  
Hiroaki Shime ◽  
Misako Matsumoto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document